The Hair Transplant Shedding Phase: Why Transplanted Hair Falls Out and When It Returns

Many patients are surprised when, two to four weeks after follicular-unit extraction or strip-harvest surgery, the newly transplanted hair shafts fall out. This shedding is a normal and expected part of the hair-transplant process, not a sign of failure. The phenomenon reflects the hair follicle's response to surgical relocation and the biology of the hair growth cycle.

Knowing what happens during the hair transplant shedding phase—and what does not—helps patients distinguish normal healing from rare complications and manage expectations during the months before visible regrowth begins.

Why transplanted hair sheds: the hair cycle explained

Human hair follicles cycle through three phases: anagen (active growth, lasting two to seven years on the scalp), catagen (a brief two-week transition), and telogen (a three-month resting phase during which the hair shaft is released) (Paus & Cotsarelis, 1999). At any moment roughly 85 to 90 percent of scalp follicles are in anagen, while 10 to 15 percent are in telogen.

When a follicular unit is extracted from the donor area and placed into a recipient-site incision, the surgical trauma and temporary interruption of blood supply push the follicle into telogen. The living root—the dermal papilla and stem cells—survives if the graft is handled properly and begins re-establishing a vascular connection within 48 to 72 hours (Goldin & Zito, 2025). However, the hair shaft that was growing at the time of surgery is released and shed, usually two to eight weeks later.

This shedding does not mean the graft has died. The follicle remains anchored in the scalp, and after a dormant period of roughly three to four months, a new anagen phase begins and fine hairs emerge. Individual responses vary; some follicles may enter anagen slightly earlier or later.

The shedding timeline week by week

The first ten days after surgery are marked by scab formation around each graft. Gentle washing, as recommended by the International Society of Hair Restoration Surgery, helps soften crusts without dislodging grafts (ISHRS post-op care). During this window grafts are vulnerable to mechanical trauma; rubbing, scratching, or vigorous shampooing can displace a graft entirely.

Between weeks two and eight, most transplanted hair shafts detach. The shedding may be gradual or occur in clusters. Patients often notice short hairs on the pillowcase or in the shower. This is the hair transplant shedding phase in its most visible form. By the end of the second month, the scalp may appear similar to—or even thinner than—its pre-surgery state, because the original miniaturized hairs are still present while the transplanted shafts have been shed.

Months one through three are sometimes called the dormant or resting period. Few visible changes occur. Beneath the surface, follicles are re-entering anagen. Around month three or four, fine, often colorless hairs begin to emerge. These early hairs are typically thin and may grow slowly. By six months, many patients see noticeable coverage, and density continues to increase through month twelve. Full maturation—including shaft caliber and pigmentation—can take twelve to eighteen months.

The table below summarizes what patients usually observe and which findings warrant contacting the surgical team:

Shedding vs shock loss vs a lost graft

Three distinct phenomena can lead to hair loss after surgery, and differentiating them is important.

Transplant shedding refers to the release of the hair shaft from a successfully implanted graft. The follicle itself remains in place and will produce a new hair in three to four months. This process is universal and expected.

Shock loss, also called telogen effluvium, is the shedding of native (non-transplanted) hair in the recipient or donor area. Surgical trauma, anesthesia, and the stress of the procedure can push nearby follicles into telogen (Hughes et al., 2024). In the recipient zone, shock loss typically affects miniaturized hairs that were already thinning; these hairs may or may not regrow, depending on whether the underlying follicle is still viable (Loh et al., 2018). Donor-area shock loss has been documented after follicular-unit extraction, particularly when large numbers of grafts are harvested in a single session (Kerure et al., 2020). Most donor-area effluvium resolves within several months, though individual outcomes vary.

Shock loss is not always preventable. Some studies have explored adjunct therapies such as platelet-rich plasma to reduce post-surgical shedding, but a 2025 systematic review found that the data remain heterogeneous and no intervention has been shown in controlled trials to reliably prevent the phenomenon (Sindhusen et al., 2025).

True graft loss occurs when an entire follicular unit is dislodged from the recipient site, typically within the first seven to ten days before the graft has anchored. This may happen if the patient rubs the scalp aggressively, sleeps face-down on the grafts, or experiences direct trauma. A lost graft is often accompanied by bleeding or an empty recipient site. Graft survival rates in experienced hands are high, and true losses are uncommon when post-operative instructions are followed (American Academy of Dermatology).

Patients sometimes confuse the normal shedding of transplanted shafts with graft loss. If a hair shaft falls out two to six weeks after surgery with no bleeding and the scalp surface is intact, the graft is almost certainly still in place.

Does everyone shed, and does more shedding mean worse results?

Nearly all transplanted grafts shed their initial hair shafts, though the visibility of shedding varies. Patients with darker hair or lighter skin may notice it more acutely. Some individuals report minimal shedding, but histologic studies suggest that even when shedding is not visible, the follicle has entered telogen and will produce a new hair shaft rather than continuing the original growth.

The amount of shedding does not correlate with final graft survival or density. A patient who sheds heavily in weeks two through four may achieve the same coverage as one who sheds less visibly. The critical variable is whether the follicles were transplanted with minimal trauma and have re-established blood supply, not the fate of the temporary hair shaft.

Conversely, seeing some transplanted hairs continue to grow beyond the typical shedding window does not indicate superior results. Those hairs will eventually be replaced as the follicle cycles, and the long-term outcome depends on the follicle's health, not the persistence of the original shaft.

What can and cannot influence the shedding phase

Because the hair transplant shedding phase is driven by the follicle's intrinsic response to surgical stress, no intervention has been shown to prevent it. The American Academy of Dermatology notes that following post-operative care instructions—gentle washing, avoiding sun exposure, refraining from smoking, and not scratching the scalp—supports healing and graft survival but does not alter the telogen phase itself.

Some patients are prescribed minoxidil or finasteride before or after surgery. These medications support native hair and may improve graft survival over the long term, but they introduce their own shedding phenomenon. Minoxidil, when first applied, can trigger a temporary increase in shedding as weak hairs are replaced by stronger ones. Finasteride may cause a brief shed as the follicle adjusts to altered androgen signaling. This medication-related shedding is separate from the transplant shedding and typically resolves within two to three months.

Nutritional status, hydration, and general health support wound healing but do not override the follicle's programmed entry into telogen. Patients sometimes ask whether vitamins, laser therapy, or platelet-rich plasma can accelerate regrowth. While some adjunct therapies are under investigation, evidence remains limited and individual responses vary (Sindhusen et al., 2025). No topical or oral agent has been validated in controlled trials to shorten the dormant period or prevent the shedding of transplanted shafts.

The most reliable factor within a patient's control is adherence to the surgeon's post-operative protocol during the first ten days, when grafts are most vulnerable to mechanical dislodgment.

When to contact the surgeon

Most shedding and scalp changes after a hair transplant fall within the range of normal healing. However, certain signs warrant prompt communication with the surgical team.

During the first two weeks, contact the surgeon if there is persistent bleeding beyond 48 hours, increasing pain that is not controlled by prescribed medication, purulent drainage, or expanding redness and warmth suggestive of infection. Fever or swelling that worsens after the third day should also be reported.

In the weeks and months following surgery, new areas of hair loss that were not present before the procedure—especially if they appear suddenly or are accompanied by scalp tenderness—may indicate shock loss or, rarely, an adverse reaction. While temporary effluvium is common, a surgeon can assess whether the shedding is expected or requires intervention.

If no regrowth is visible by five months, a follow-up visit is appropriate. Individual timelines vary, but complete absence of new hair beyond this point may indicate that grafts did not survive or that an underlying condition is affecting follicle function. Most surgeons schedule routine follow-up visits at three, six, and twelve months to document progress and address concerns.

Patients should not attempt to self-diagnose graft failure based on shedding alone. The shedding phase can be emotionally challenging, but it is a temporary stage in a process that unfolds over a year or more.

For individuals considering a hair-restoration procedure or experiencing unexpected changes after surgery, a detailed consultation—such as the Follicular Health Assessment offered by Dr. Charles Pereyra, a board-certified emergency physician and member of the International Society of Hair Restoration Surgery—can provide clarity. Dr. Pereyra performs micro-graft follicular-unit extraction procedures and follows patients through every phase of recovery at Springs Rejuvenation Hair locations in Miami, Los Angeles, Austin, Atlanta, and New York. Reach the clinical team at (888) 503-4482.

Medical disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages; it is not FDA approved to treat any disease. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. This page is educational and is not medical advice; always consult a qualified physician. Written and reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director, Springs Rejuvenation Hair.